Additional Payments Receivable On Milestone Achievements

No definition available.

Name:	aria_AdditionalPaymentsReceivableOnMilestoneAchievements
Namespace Prefix:	aria_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Buy-in License Agreement, Royalty Payment Rate

+ References

No definition available.

+ Details

Name:	aria_BuyinLicenseAgreementRoyaltyPaymentRate
Namespace Prefix:	aria_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

Disposal Group, Working Capital Payment Adjustment

+ References

No definition available.

+ Details

Name:	aria_DisposalGroupWorkingCapitalPaymentAdjustment
Namespace Prefix:	aria_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Divestiture of Interest in Consolidated Subsidiaries, Liabilities Transferred

+ References

No definition available.

+ Details

Name:	aria_DivestitureofInterestinConsolidatedSubsidiariesLiabilitiesTransferred
Namespace Prefix:	aria_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

License Agreement, Expiration, Potential Extension Term

+ References

No definition available.

+ Details

Name:	aria_LicenseAgreementExpirationPotentialExtensionTerm
Namespace Prefix:	aria_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

License Agreement, Expiration Term

+ References

No definition available.

+ Details

Name:	aria_LicenseAgreementExpirationTerm
Namespace Prefix:	aria_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

License Agreement, Option, End of Exercise Term

+ References

No definition available.

+ Details

Name:	aria_LicenseAgreementOptionEndofExerciseTerm
Namespace Prefix:	aria_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

License Agreement, Option, Start of Exercise Term Following Agreement Date

+ References

No definition available.

+ Details

Name:	aria_LicenseAgreementOptionStartofExerciseTermFollowingAgreementDate
Namespace Prefix:	aria_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

License Agreement, Option, Transition Period Following Exercise

+ References

No definition available.

+ Details

Name:	aria_LicenseAgreementOptionTransitionPeriodFollowingExercise
Namespace Prefix:	aria_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

License Agreement, Payments Receivable

+ References

No definition available.

+ Details

Name:	aria_LicenseAgreementPaymentsReceivable
Namespace Prefix:	aria_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Revenue from multiple-deliverable arrangements that include licensing fees and collaboration arrangements. Licensing revenue is consideration received from another party for the right to use, but not own, certain of the entity's intangible assets. Licensing arrangements include, but are not limited to, rights to use a patent, copyright, technology, manufacturing process, software or trademark. Licensing fees are generally, but not always, fixed as to amount and not dependent upon the revenue generated by the licensing party. An entity may receive licensing fees for licenses that also generate royalty payments to the entity. Collaboration agreements include, but are not limited to, license fees, research and development, up-front and milestone payments.

+ References

No definition available.

+ Details

Name:	aria_LicenseAndCollaborationRevenue
Namespace Prefix:	aria_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

License Arrangement with Counterparty, Contribution Receivable

+ References

No definition available.

+ Details

Name:	aria_LicenseArrangementwithCounterpartyContributionReceivableForYearOne
Namespace Prefix:	aria_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Definition

License Arrangement with Counterparty, Contribution Receivable For Year Two

+ References

No definition available.

+ Details

Name:	aria_LicenseArrangementwithCounterpartyContributionReceivableForYearTwo
Namespace Prefix:	aria_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Definition

Amount of deferred revenue as of balance sheet date. Deferred revenue represents collections of cash or other assets related to a revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 605
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 13.A.3)
-URI http://asc.fasb.org/extlink&oid=65893310&loc=d3e214044-122780

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 605
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 13.A.4(a).Q1)
-URI http://asc.fasb.org/extlink&oid=65893310&loc=d3e214044-122780

+ Details

Name:	us-gaap_DeferredRevenue
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

The excess amount received or due over net assets in a transaction accounted for as a divestiture where a subsidiary, business or operating assets are "sold" by the entity to a newly formed, thinly capitalized, highly leveraged buyer. This gain is not yet recognized and is disclosed on the balance sheet as an offset against the carrying amount of the securities received.

+ References

No definition available.

+ Details

Name:	us-gaap_DisposalGroupDeferredGainOnDisposal
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Amount of consideration received or receivable for the disposal of assets and liabilities, including discontinued operation.

+ References

No definition available.

+ Details

Name:	us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Definition

Amount of foreign currency translation gain (loss) in the disposal group, including discontinued operation, recognized in the statement of income as a result of the sale or complete or substantially complete liquidation of an investment in a foreign entity.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 830
-SubTopic 30
-Section 45
-Paragraph 20
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=64808268&loc=d3e32211-110900

+ Details

Name:	us-gaap_DisposalGroupIncludingDiscontinuedOperationForeignCurrencyTranslationGainsLosses
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Amount before tax of gain (loss) recognized on the sale or disposal of a disposal group. Excludes discontinued operations.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 360
-SubTopic 10
-Section 45
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=68055307&loc=d3e2443-110228

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 360
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=64862545&loc=d3e2941-110230

+ Details

Name:	us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Amount of gain (loss) on sale or disposal of equity in securities of subsidiaries.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 225
-Section S99
-Paragraph 1
-Subparagraph (13)(g)
-URI http://asc.fasb.org/extlink&oid=6879574&loc=d3e536633-122882

+ Details

Name:	us-gaap_GainOrLossOnSaleOfStockInSubsidiary
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

The cash inflow associated with the deconsolidation of a previously consolidated subsidiary or the sale of investment in consolidated subsidiaries (generally greater than 50 percent).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 12
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3179-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Investing Activities
-URI http://asc.fasb.org/extlink&oid=6516133

+ Details

Name:	us-gaap_ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

No definition available.

+ Details

Name:	us-gaap_SubsidiarySaleOfStockLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Details

Name:	us-gaap_CounterpartyNameAxis=aria_IncyteCorporationMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_OtherCommitmentsAxis=aria_LicenseAgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_RangeAxis=us-gaap_MinimumMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_RangeAxis=us-gaap_MaximumMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_OtherCommitmentsAxis=aria_LicenseAgreementAcquirerOptionMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=aria_ARIADPharmaceuticalsLuxembourgS.a.r.lMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Incyte Transaction (Details) - USD ($)		3 Months Ended		9 Months Ended
Incyte Transaction (Details) - USD ($)	Jun. 01, 2016	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2016	Sep. 30, 2015
Subsidiary, Sale of Stock [Line Items]
Proceeds from the Incyte transaction, net of $4,484 of cash transferred				$ 143,149,000	$ 0
Consideration allocated to sale of business				131,734,000	0
Loss from reclassification of currency translation adjustment and pension obligation adjustments to earnings upon sale of European operations				2,939,000	0
Net gain recorded on transaction		$ 3,042,000	$ 0	131,706,000	0
Recognized revenue from royalties and development and regulatory cost milestones		11,716,000	$ 1,527,000	16,479,000	$ 3,038,000
Incyte \| License agreement
Subsidiary, Sale of Stock [Line Items]
Additional milestone payments (up to)	$ 135,000,000
Contribution receivable for funding trials in 2016 (up to)	7,000,000
Contribution receivable for funding trials in 2017 (up to)	$ 7,000,000
License agreement expiration potential extension term	6 months
License agreement expiration term	7 years
Proceeds from from royalties and development and regulatory cost milestone payments		8,100,000
Recognized revenue from royalties and development and regulatory cost milestones		7,100,000
Deferred revenue from royalties and development and regulatory cost milestone payments		1,000,000		1,000,000
Incyte \| License agreement \| Minimum
Subsidiary, Sale of Stock [Line Items]
Royalty payment rate (as a percent)	32.00%
Incyte \| License agreement \| Maximum
Subsidiary, Sale of Stock [Line Items]
Royalty payment rate (as a percent)	50.00%
Incyte \| License Agreement Acquirer Option
Subsidiary, Sale of Stock [Line Items]
Beginning of exercise term of acquirer's option within license agreement	2 years
End of exercise term of acquirer's option within license agreement	6 years
Transition period to repurchase license agreement after acquirer's exercise of option within license agreement	1 year
Incyte \| License Agreement Acquirer Option \| Minimum
Subsidiary, Sale of Stock [Line Items]
Royalty payment rate (as a percent)	20.00%
Incyte \| License Agreement Acquirer Option \| Maximum
Subsidiary, Sale of Stock [Line Items]
Royalty payment rate (as a percent)	25.00%
Disposal Group, Disposed of by Sale, Not Discontinued Operations \| ARIAD Pharmaceuticals (Luxembourg) S.a.r.l
Subsidiary, Sale of Stock [Line Items]
Total consideration for the Incyte transaction (including upfront payment)	$ 140,000,000
Working capital payment	3,100,000
Proceeds from the Incyte transaction, net of $4,484 of cash transferred	143,100,000	150,600,000
Net liabilities transferred to Incyte	7,500,000
Consideration allocated to sale of business	131,900,000
Consideration allocated to undelivered elements	18,700,000
Loss from reclassification of currency translation adjustment and pension obligation adjustments to earnings upon sale of European operations	$ 2,900,000
Net gain recorded on transaction		$ 129,000,000		$ 129,000,000